This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer (BCG/EMDA-MMC)

This study has been completed.
Sponsor:
Collaborator:
University of L'Aquila
Information provided by (Responsible Party):
Savino M. Di Stasi, University of Rome Tor Vergata
ClinicalTrials.gov Identifier:
NCT01442519
First received: July 29, 2011
Last updated: September 27, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)
Publications: